Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI.

PURPOSE Our goal was to demonstrate that medical therapy in patients with smell loss (hyposmia) that restored olfactory function toward or to normal could be verified and quantitated by functional MRI (fMRI) of brain and that visual representation of these changes could be used to identify these patients. METHOD Multislice FLASH MR or echo planar MR brain scans were obtained in four patients with hyposmia in response to three olfactory stimuli both before and after treatment with theophylline. Activation images were derived using correlation analysis, and ratios of brain area activated to total brain area were obtained. RESULTS Prior to treatment, all patients stated that they could not smell; these losses were confirmed by standard psychophysical tests. At this time, fMRI brain activation in response to odors was significantly less than that measured in normal volunteers and similar to activation measured previously in other patients with a similar type of hyposmia. After treatment, subjective smell function improved in three patients and no improvement occurred in one; results were confirmed by psychophysical tests. In each patient in whom smell acuity improved, brain activation in response to each odor increased in each section and mean activation increased significantly for each odor. Activation increased in all regions previously associated with olfactory stimulation and was particularly apparent in orbitofrontal cortex, frontal lobe component of cingulate gyri, temporal lobe gyri, and hippocampus. There also was consistent activation in superior, middle, and inferior frontal lobe gyri. There were no changes in brain activation after treatment in the patient in whom smell did not improve. CONCLUSION These results demonstrate that theophylline is an effective therapeutic agent to correct hyposmia in some patients with smell loss. These changes have been documented by fMRI brain scans using olfactory stimuli. This is the first study in which this type of objective improvement following medical treatment has been demonstrated in patients with hyposmia.

[1]  J. Daly.  Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.

[2]  P. Hamet,et al.  Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. , 1977, Prostaglandins.

[3]  Doron Lancet,et al.  Odorant-sensitive adenylate cyclase may mediate olfactory reception , 1985, Nature.

[4]  A. Kaneko,et al.  High density cAMP-gated channels at the ciliary membrane in the olfactory receptor cell. , 1991, Neuroreport.

[5]  J. Snow,et al.  Histopathology of the olfactory pathway due to ischemia , 1984, The Laryngoscope.

[6]  D. T. Jones,et al.  Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. , 1989, Science.

[7]  S. Frings,et al.  Current recording from sensory cilia of olfactory receptor cells in situ. I. The neuronal response to cyclic nucleotides , 1991, The Journal of general physiology.

[8]  B A Berkowitz,et al.  Release of norepinephrine in the central nervous system by theophylline and caffeine. , 1970, European journal of pharmacology.

[9]  R. Anholt.  Molecular neurobiology of olfaction. , 1993, Critical reviews in neurobiology.

[10]  G. Canonica,et al.  Theophylline and the immune response: in vitro and in vivo effects. , 1988, Clinical immunology and immunopathology.

[11]  B Waldeck,et al.  Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain , 1971, The Journal of pharmacy and pharmacology.

[12]  M. Roth,et al.  Inhibition of natural killer cell activity by therapeutic levels of theophylline. , 1993, American journal of respiratory cell and molecular biology.

[13]  D. Lancet,et al.  Primary structure of cAMP‐gated channel from bovine olfactory epithelium , 1990, FEBS letters.

[14]  Geoffrey H. Gold,et al.  A cyclic nucleotide-gated conductance in olfactory receptor cilia , 1987, Nature.

[15]  Randall R. Reed,et al.  Identification of a specialized adenylyl cyclase that may mediate odorant detection. , 1990, Science.

[16]  E. Shooter,et al.  The biology and mechanism of action of nerve growth factor. , 1982, Annual review of biochemistry.

[17]  R. Axel,et al.  A novel multigene family may encode odorant receptors: A molecular basis for odor recognition , 1991, Cell.

[18]  K Kurihara,et al.  High activity of adenyl cyclase in olfactory and gustatory organs. , 1972, Biochemical and biophysical research communications.

[19]  S. Ghosh,et al.  delta-9-Tetrahydrocannabinol inhibits the binding of theophylline to mammalian neuronal and non-neuronal membranes. , 1993, Biochemical pharmacology.

[20]  G. Dodd,et al.  Evidence for the specific involvement of cyclic AMP in the olfactory transduction mechanism. , 1977, Biochemical and biophysical research communications.

[21]  F. R. Smith,et al.  Defects of taste and smell in patients with hypothyroidism. , 1975, The American journal of medicine.

[22]  B. Volovitz,et al.  Induction of suppressor T cells in asthmatic children by theophylline treatment , 1983, Clinical allergy.

[23]  C. S. Lin,et al.  Mapping brain activation to odorants in patients with smell loss by functional MRI. , 1998, Journal of computer assisted tomography.

[24]  C. S. Lin,et al.  Functional MRI of human olfaction. , 1997, Journal of computer assisted tomography.

[25]  G. Chiappara,et al.  Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophages. , 1994, The European respiratory journal.

[26]  F. Bloom.  The role of cyclic nucleotides in central synaptic function. , 1975, Reviews of physiology, biochemistry and pharmacology.

[27]  R. Vestal,et al.  Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate. , 1988, The American review of respiratory disease.

[28]  F. R. Smith,et al.  Hyposmia in acute viral hepatitis. , 1971, Lancet.

[29]  B. Ferruà,et al.  Regulation of interleukin 2 synthesis by cAMP in human T cells. , 1987, Journal of immunology.

[30]  Tyler S. Lorig,et al.  Brain and odor: I. Alteration of human EEG by odor administration , 1988, Psychobiology.

[31]  E. Shooter,et al.  The action of nerve growth factor and dibutyryl adenosine cyclic 3':5'- monophosphate on rat pheochromocytoma reveals distinct stages in the mechanisms underlying neurite outgrowth , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  G M Shepherd,et al.  Single odor-sensitive channels in olfactory receptor neurons are also gated by cyclic nucleotides , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  David P. Salmon,et al.  Olfactory thresholds are associated with degree of dementia in Alzheimer's disease , 1990, Neurobiology of Aging.

[34]  Y. Nakagawa,et al.  Theophylline-induced nociceptive behavioral response in mice: Possible indirect interaction with spinal N-methyl-d-aspartate receptors , 1993, Neurochemistry International.

[35]  M. Zarrindast,et al.  On the mechanisms by which theophylline changes core body temperature in mice. , 1994, European journal of pharmacology.

[36]  W. Thompson.  Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. , 1991, Pharmacology & therapeutics.

[37]  T Allison,et al.  Human odorant evoked responses: effects of trigeminal or olfactory deficit. , 1971, Electroencephalography and clinical neurophysiology.

[38]  William R. Klemm,et al.  Topographical EEG maps of human responses to odors , 1992 .

[39]  D. Taylor,et al.  Microiontophoretic studies of the effects of cyclic nucleotides on excitability of neurones in the rat cerebral cortex , 1977, The Journal of physiology.

[40]  K. Yau,et al.  Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons , 1990, Nature.

[41]  H. Watanabe,et al.  Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors , 1986, Neuropharmacology.

[42]  A Sattin,et al.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. , 1970, Molecular pharmacology.

[43]  Dieter Mrowinski,et al.  Olfactory Evoked Potentials and Contingent Negative Variation Simultaneously Recorded for Diagnosis of Smell Disorders , 1993, The Annals of otology, rhinology, and laryngology.

[44]  B A Berkowitz,et al.  The effect of caffeine and theophylline on the disposition of brain serotonin in the rat. , 1971, European journal of pharmacology.

[45]  W S Cain,et al.  Clinical evaluation of olfaction. , 1983, American journal of otolaryngology.